Pfizer Eyes EU Pegfilgrastim Roll-Out By 1 April As US Launch Is Confirmed
No Update On Infringement Proceedings Over Protein Purification Patent
Pfizer's pegfilgrastim product, Nyvepria, is the fourth biosimilar Neulasta product available in the US • Source: Shutterstock